Recently, the Multidisciplinary Association for Psychedelic Studies (MAPS) has received FDA-approval for research into the possible benefits of MDMA in the treatment of post-traumatic stress disorder. The results thus far have been uniquely promising.<ref>[https://www.washingtonpost.com/wp-dyn/content/article/2007/11/20/AR2007112001777_pf.html The Peace Drug]</ref> | Recently, the Multidisciplinary Association for Psychedelic Studies (MAPS) has received FDA-approval for research into the possible benefits of MDMA in the treatment of post-traumatic stress disorder. The results thus far have been uniquely promising.<ref>[https://www.washingtonpost.com/wp-dyn/content/article/2007/11/20/AR2007112001777_pf.html The Peace Drug]</ref> |